AI assistant
Sending…
Liquidia Corp — Director's Dealing 2025
Nov 7, 2025
31694_dirs_2025-11-07_9030d4e4-a341-4d3e-a9c3-40e5c8557f8a.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Liquidia Corp (LQDA)
CIK: 0001819576
Period of Report: 2025-11-05
Reporting Person: Saggar Rajeev (Chief Medical Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-11-05 | Common Stock | S | 4918 | $27.00 | Disposed | 243012 | Direct |
| 2025-11-05 | Common Stock | S | 66463 | $27.00 | Disposed | 176549 | Direct |
Footnotes
F1: Includes (i) 26,041 unvested restricted stock units ("RSUs") of the 83,333 RSUs granted to the Reporting Person on January 11, 2023, (ii) 31,777 unvested RSUs of the 56,492 RSUs granted to the Reporting Person on January 11, 2024, (iii) 71,780 RSUs granted to the Reporting Person on January 11, 2025, none of which have vested as of the date of this Form 4, and (iv) 2,221 shares of common stock acquired under the Liquidia Corporation 2020 Employee Stock Purchase Plan.
More from Liquidia Corp
Interim / Quarterly Report
2026
May 11
Regulatory Filings
2026
May 11
Annual Report
2026
Apr 24
Regulatory Filings
2026
Mar 27
Regulatory Filings
2026
Mar 26
Director's Dealing
2026
Mar 25
Director's Dealing
2026
Mar 17
Director's Dealing
2026
Mar 17
Director's Dealing
2026
Mar 17
Director's Dealing
2026
Mar 3